Propanc Biopharma Statistics
Total Valuation
PPCB has a market cap or net worth of 92.89 million. The enterprise value is 94.09 million.
| Market Cap | 92.89M |
| Enterprise Value | 94.09M |
Important Dates
The next estimated earnings date is Tuesday, September 30, 2025.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PPCB has 11.61 million shares outstanding.
| Current Share Class | 11.61M |
| Shares Outstanding | 11.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +32,311.73% |
| Owned by Insiders (%) | 71.54% |
| Owned by Institutions (%) | 4.30% |
| Float | 2.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.13 |
| P/TBV Ratio | 5.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.70 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.24 |
| Quick Ratio | 0.01 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -135.00 |
Financial Efficiency
Return on equity (ROE) is -767.20% and return on invested capital (ROIC) is -406.50%.
| Return on Equity (ROE) | -767.20% |
| Return on Assets (ROA) | -298.55% |
| Return on Invested Capital (ROIC) | -406.50% |
| Return on Capital Employed (ROCE) | -296.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -27.61M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -237 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +190,138.10% in the last 52 weeks. The beta is 19,161.25, so PPCB's price volatility has been higher than the market average.
| Beta (5Y) | 19,161.25 |
| 52-Week Price Change | +190,138.10% |
| 50-Day Moving Average | 4.45 |
| 200-Day Moving Average | 2.84 |
| Relative Strength Index (RSI) | 70.46 |
| Average Volume (20 Days) | 1,563 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.89M |
| Pretax Income | -55.21M |
| Net Income | -55.21M |
| EBITDA | -53.89M |
| EBIT | -53.89M |
| Earnings Per Share (EPS) | -51.78 |
Balance Sheet
The company has 50,760 in cash and 1.25 million in debt, giving a net cash position of -1.20 million or -0.10 per share.
| Cash & Cash Equivalents | 50,760 |
| Total Debt | 1.25M |
| Net Cash | -1.20M |
| Net Cash Per Share | -0.10 |
| Equity (Book Value) | 18.09M |
| Book Value Per Share | 1.56 |
| Working Capital | 5.39M |
Cash Flow
| Operating Cash Flow | -637,948 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PPCB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -59.43% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.0000167.
| Last Split Date | Jan 29, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0000167 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |